• Sebastiaan Velthuis, Elisabetta Buscarini, Johannes J Mager, Veronique M M Vorselaars, Marco W F van Gent, Pietro Gazzaniga, Guido Manfredi, Cesare Danesino, Arjen L Diederik, Jan A Vos, Silvia Gandolfi, Repke J Snijder, Cornelis J J Westermann, and Martijn C Post.
• Dept of Cardiology, St Antonius Hospital, Nieuwegein S.Velthuis@antoniusziekenhuis.nl.
• Eur. Respir. J. 2014 Jul 1;44(1):150-9.

AbstractThis study aimed to investigate whether pulmonary shunt grade on transthoracic contrast echocardiography (TTCE) predicts the size of pulmonary arteriovenous malformations (PAVMs) on chest computed tomography (CT) and subsequent feasibility for transcatheter embolotherapy. We prospectively included 772 persons with possible or definite hereditary haemorrhagic telangiectasia, who underwent both TTCE and chest CT for screening of PAVMs. A quantitative three-point grading scale was used to classify the pulmonary shunt size on TTCE (grade 1-3). Transcatheter embolotherapy was performed for PAVMs deemed large enough for endovascular closure on chest CT. TTCE documented pulmonary shunting in 510 (66.1%) patients. The positive predictive value of a pulmonary shunt grade 1, 2 and 3 on TTCE for presence of PAVMs on chest CT was 13.4%, 45.3% and 92.5%, respectively (p<0.001). None of the 201 persons with a pulmonary shunt grade 1 on TTCE had PAVMs on chest CT large enough for transcatheter embolotherapy, while 38 (25.3%) and 123 (77.4%) individuals with a pulmonary shunt grade 2 and 3 on TTCE, respectively, underwent endovascular closure of PAVMs. Pulmonary shunt grade on TTCE predicts the size of PAVMs on chest CT and their feasibility for subsequent transcatheter embolotherapy. Chest CT can be safely withheld from all persons with a pulmonary shunt grade 1 on TTCE, as any PAVM found in these subjects will be too small for transcatheter embolotherapy.© ERS 2014.

26 keywords...

hide…